bevacizumab,atezolizumab,Irinotecan,Oxaliplatin,L-Leucovorin,5-fluorouracil
Roche
['biomarker', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'atezo', 'crcsm', 'atezotribe', 'core i']
atezotribe: io predominantly improving outcomes for dmmr crc. interesting to see another biomarker (immunoscore ic) predicting response which can be seen in pmmr! #asco23 #crcsm 
GI Oncologist at @IUCancerCenter. @uw_hemeoncpc and @UChicagomed alum. Tweets are my own.